Status:
UNKNOWN
Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing
Lead Sponsor:
Soroka University Medical Center
Conditions:
Sleep Disordered Breathing
Eligibility:
All Genders
2-10 years
Phase:
PHASE4
Brief Summary
This study will assess in a double blind placebo controlled fashion the effects of a 12 week course of oral montelukast/placebo on polysomnographic and radiological findings and will characterize the ...
Eligibility Criteria
Inclusion
- 2-10 years old
- 1\<AHI\<8 measured in an overnight PSG
- \-
Exclusion
- Asthma Previous use or allergy to montelukast Use of antibiotics in the previous 3 weeks Use of corticosteroids in the previous 3 months Craniofacial dysmorphism Genetic or metabolic defined illnesses Adenotonsillectomy or adenoidectomy in the past
- \-
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00299910
Start Date
March 1 2005
Last Update
May 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Sleep Center, Soroka University Medical Center
Beersheba, Israel